Applied Genetic Technologies (NASDAQ: AGTC) reported Q3 EPS of ($0.05), $0.04 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $10.45 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.